对新突变的结构和功能影响的计算调查,这些突变是在卵巢癌细胞系的向外原体中发现的
Rucha M Wadapurkar1, Aruna Sivaram1, Renu Vyas1
1MIT School of Bioengineering Sciences & Research, MIT-ADT University, Pune, Maharashtra, India.
Journal of biomolecular structure & dynamics
|February 9, 2024
概括
研究人员使用下一代测序在6个卵巢癌基因中发现了8种新的临床显著突变. 这些突变影响蛋白质结构和功能,为早期检测卵巢癌提供了潜在的新生物标志物和药物标.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 计算生物学 计算生物学
背景情况:
- 由于缺乏敏感和特定的生物标志物,卵巢癌的诊断往往会延迟.
- 突变积累驱动癌症的进展,使得突变识别对诊断至关重要.
研究的目的:
- 为了识别卵巢癌细胞系中的新突变.
- 分析已识别的突变的结构和功能影响.
- 探索卵巢癌的潜在生物标志物和治疗点.
主要方法:
- 对15个来自13个卵巢癌细胞系的下一代测序样本进行了全面分析.
- 对突变对蛋白质结构,稳定性和动态的影响进行深入的计算分析.
- 蛋白与蛋白相互作用 (PPI) 网络分析,以了解途径的参与.
- 实验室验证研究,包括对CTNNB1基因超变性的评估.
主要成果:
- 在六种卵巢癌类瘤基因中发现了八种临床意义上的新突变:SMARCA4,ARID1A,PPPP2R1A,CTNNB1,DICER1和PIK3CA.
- 计算分析显示突变对蛋白质稳定性,溶剂可访问的表面积,分子动力学和关键领域内的功能产生不利影响.
- PPI网络分析表明,这些基因参与了与癌症相关的重要途径.
- 在体外研究证实了CTNNB1基因的超变性.
结论:
- 这项研究确定了卵巢癌基因中的关键突变,具有显著的结构和功能后果.
- 这些已识别的突变代表了早期诊断的潜在生物标志物和卵巢癌治疗的新治疗标.
更多相关视频
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...


